Clinical Trials Logo

Clinical Trial Summary

The main purpose of this clinical trial is to determine the safety and effects of the study drug, sorafenib, in adults diagnosed with hepatopulmonary syndrome (HPS). The study will evaluate how well the drug is tolerated and its effect on the level of oxygen in the blood and the function of the lung vessels.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02021929
Study type Interventional
Source University of Pennsylvania
Contact
Status Terminated
Phase Phase 2
Start date March 2014
Completion date January 2018

See also
  Status Clinical Trial Phase
Recruiting NCT01676597 - Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome N/A
Terminated NCT01518595 - Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis Phase 2
Completed NCT00362752 - A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome Phase 2
Active, not recruiting NCT03092401 - Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study N/A
Not yet recruiting NCT05373134 - Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome N/A
Completed NCT02148536 - Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
Terminated NCT00593658 - Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome Phase 1
Recruiting NCT03435406 - Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China N/A
Recruiting NCT04004104 - Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia N/A
Recruiting NCT04577001 - Letrozole in Patients With Hepatopulmonary Syndrome Phase 2